TSX:TLRY (Aphria)
About TLRY
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Aphria (TSX: TLRY) Latest News

Cannabis Stocks
These 5 Cannabis Stocks Are High-Risk Holdings Like Bitcoin

Cannabis Stocks
2 Dirt-Cheap Cannabis Stocks That Could Soar in 2022

Cannabis Stocks
No Respite for Aurora Cannabis Investors

Investing
Down Over 50%: Should You Buy These 3 Canadian Stocks?

Investing
4 Cheap Stocks to Snag During This Market Correction

Dividend Stocks
2021 TSX IPO Recap: 3 Outperformers and 1 Dud

Tech Stocks
These Were the Most Popular Stocks in Canada Last Week

Cannabis Stocks
What’s Hot on the TSX Today?

Cannabis Stocks
Why Cannabis Stocks Surged on Monday

Cannabis Stocks
Better Cannabis Stock: Tilray vs. Canopy Growth

Energy Stocks
TSX Today: Top 5 Canadian Stocks to Watch on Wednesday, October 20
